Histamine-induced Ca(2+) signaling in human valvular myofibroblasts.
In this study, we examined histamine-induced calcium signaling in cultured human valvular myofibroblasts (hVMFs), which are the most prominent interstitial cells in cardiac valves mediating valvular contraction, extracellular matrix secretion, and wound repair. Despite the functional importance of VMFs in cardiac valves, the cellular-signaling pathways, especially those mediated by Ca(2+), are still poorly understood. Using fluorescence imaging microscopy, we measured intracellular Ca(2+) ([Ca(2+)](i)) levels in fura-2-loaded hVMFs. Activation of H(1) receptors released Ca(2+) from one compartment of the endoplasmic reticulum (ER) of hVMFs, but did not induce Ca(2+) entry. This histamine-induced Ca(2+) release was oscillatory and dependent on Ca(2+) re-uptake into the ER by sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA). Application of the reversible SERCA blocker, cyclopiazonic acid (CPA), after depletion of the histamine-sensitive Ca(2+) store revealed the presence of a second, smaller histamine-insensitive Ca(2+) store in the ER. The Ca(2+) content ratio of the histamine-sensitive and histamine-insensitive Ca(2+) stores in the ER was found to be approximately 1.15:1. Another effect of CPA in hVMFs was the activation of store-operated Ca(2+) channels, as demonstrated by maintained [Ca(2+)](i) elevation as well as accelerated Mn(2+) entry. In conclusion, this study establishes for the first time an agonist-induced Ca(2+)-signaling pathway in hVMFs.
Liang
Willmann
W
Department of Pathology, The iCAPTUR4E Centre, St Paul's Hospital, University of British Columbia, Vancouver, Canada V6T 1Z3.
McDonald
Paul
P
McManus
Bruce
B
van Breemen
Cornelis
C
Wang
Xiaodong
X
D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology*; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism*; D006351:Heart Valves / Q000187:drug effects / Q000378:metabolism*; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D011969:Receptors, Histamine H1 / Q000378:metabolism; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases
D004791:Enzyme Inhibitors; D007211:Indoles; D011969:Receptors, Histamine H1; D006632:Histamine; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D000252:Calcium-Transporting ATPases; C000543:cyclopiazonic acid